FDA Says Merck’s Chronic Cough Treatment Didn’t Show Substantial Evidence of Effectiveness
Wall Street Journal
The pharmaceutical company said the FDA was responding to its new drug application for gefapixant.
Wall Street Journal
The pharmaceutical company said the FDA was responding to its new drug application for gefapixant.